TY - JOUR A1 - Kittler, Katrin A1 - Hurtaud-Pessel, D. A1 - Maul, Ronald A1 - Kolrep, F. A1 - Fessard, V. T1 - In vitro metabolism of the cyanotoxin cylindrospermopsin in HepaRG cells and liver tissue fractions N2 - No evidence for phase I metabolites of the cyanotoxin cylindrospermopsin (CYN) was given using HepaRG cells and different liver tissue fractions when studying metabolic conversion. Although the application of ketoconazole, a CYP3A4 inhibitor, led to a decreased cytotoxicity of CYN, no metabolites were detected applying high resolution mass spectrometry. Quantification of non-modified CYN led to recovery rates of almost 100%. Consequently, reduction of CYN toxicity in the presence of metabolism inhibiting agents must be attributed to alternative pathways. KW - Cylindrospermopsin KW - Metabolism KW - Liver tissue fractions KW - HepaRG cells KW - LC-HRMS KW - Quantification KW - Cyanotoxin PY - 2016 U6 - https://doi.org/10.1016/j.toxicon.2015.11.007 SN - 0041-0101 SN - 1879-3150 VL - 110 SP - 47 EP - 50 PB - Elsevier CY - Oxford [u.a.] AN - OPUS4-35222 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -